LC
IOVA icon

Lindbrook Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Lindbrook Capital’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$20.1K Buy
6,021
+3,116
+107% +$16.1K ﹤0.01% 1352
2024
Q4 		$21.5K Sell
2,905
-79
-3% -$732 ﹤0.01% 1247
2024
Q3 		$28K Buy
2,984
+292
+11% +$2.77K ﹤0.01% 1104
2024
Q2 		$21.6K Buy
2,692
+44
+2% +$472 ﹤0.01% 1207
2024
Q1 		$39.2K Buy
2,648
+35
+1% +$407 ﹤0.01% 884
2023
Q4 		$21.2K Buy
2,613
+1,079
+70% +$5.65K ﹤0.01% 1145
2023
Q3 		$6.98K Buy
1,534
+178
+13% +$1.16K ﹤0.01% 1595
2023
Q2 		$9.55K Sell
1,356
-1,114
-45% -$7.97K ﹤0.01% 1494
2023
Q1 		$15.1K Sell
2,470
-737
-23% -$5.08K ﹤0.01% 1209
2022
Q4 		$20.5K Buy
3,207
+2,232
+229% +$17.4K ﹤0.01% 1051
2022
Q3 		$9K Sell
975
-45
-4% -$519 ﹤0.01% 1372
2022
Q2 		$11K Sell
1,020
-89
-8% -$1.17K ﹤0.01% 1215
2022
Q1 		$18K Sell
1,109
-16
-1% -$247 ﹤0.01% 1045
2021
Q4 		$21K Buy
1,125
+1,053
+1,463% +$23.2K ﹤0.01% 998
2021
Q3 		$2K Sell
72
-48
-40% -$1.13K ﹤0.01% 1552
2021
Q2 		$3K Buy
+120
New +$3.12K ﹤0.01% 1475
2020
Q3 		– Sell
-1,000
Closed -$27K – 1795
2020
Q2 		$27K Buy
+1,000
New +$32.9K 0.01% 522
2020
Q1 		– Sell
-500
Closed -$14K – 1763
2019
Q4 		$14K Buy
+500
New +$11.4K ﹤0.01% 829
2019
Q2 		– Sell
-750
Closed -$7K – 1449
2019
Q1 		$7K Buy
+750
New +$7.29K ﹤0.01% 992

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lindbrook Capital's IOVA Position: Q1 2025 in Review

Lindbrook Capital increased its Iovance Biotherapeutics (IOVA) stake by 107% in Q1 2025, buying an estimated $16.1K and bringing the position to 6,021 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Lindbrook Capital first reported a position in IOVA in Q1 2019 and has held it in 19 quarters since. The position peaked at $39.2K in Q1 2024. 301 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Lindbrook Capital held 6,021 shares of Iovance Biotherapeutics worth $20.1K as of Q1 2025.
  • Lindbrook Capital bought 3,116 Iovance Biotherapeutics shares in Q1 2025, an estimated $16.1K.
  • Iovance Biotherapeutics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1352 holding.
  • Lindbrook Capital first reported a position in Iovance Biotherapeutics in Q1 2019 and has held it in 19 quarters since.
  • Lindbrook Capital's Iovance Biotherapeutics position peaked at $39.2K in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.